{"entity":{"type":"insider","cik":"0001448784","url":"/insider/0001448784","json_url":"/insider/0001448784.json","name":"Growth Equity Opportunities Fund, LLC","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":4,"first":"2010-07-02","last":"2014-08-29","span_basis":"filed_date"},"name_variants":[{"name":"Growth Equity Opportunities Fund, LLC","source":"filing","n_filings":4,"first_seen":"2010-07-02","last_seen":"2014-08-29"}],"transactions":[{"id":6642362,"accession":"0001181431-14-030566","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-14-030566","line_url":"/filing/0001181431-14-030566#line-3","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11600.0,"shares_display":"11,600","price_per_share":7.506,"price_display":"7.51","price_state":"stated","total_value":87069.6,"total_display":"87,069.60","total_whole":"87,070","shares_owned_after":4659333.0,"shares_owned_after_display":"4,659,333","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-29","filed_date":"2014-08-29","scope":"insider"},{"id":6642355,"accession":"0001181431-14-030566","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-030566","line_url":"/filing/0001181431-14-030566#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":146800.0,"shares_display":"146,800","price_per_share":7.8668,"price_display":"7.87","price_state":"stated","total_value":1154846.24,"total_display":"1,154,846.24","total_whole":"1,154,846","shares_owned_after":4670933.0,"shares_owned_after_display":"4,670,933","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-28","filed_date":"2014-08-29","scope":"insider"},{"id":6642350,"accession":"0001181431-14-030566","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-030566","line_url":"/filing/0001181431-14-030566#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC; New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":108300.0,"shares_display":"108,300","price_per_share":8.17,"price_display":"8.17","price_state":"stated","total_value":884811.0,"total_display":"884,811.00","total_whole":"884,811","shares_owned_after":4817733.0,"shares_owned_after_display":"4,817,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-27","filed_date":"2014-08-29","scope":"insider"},{"id":7066890,"accession":"0001181431-14-028995","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-14-028995","line_url":"/filing/0001181431-14-028995#line-2","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":35540.0,"shares_display":"35,540","price_per_share":6.7583,"price_display":"6.76","price_state":"stated","total_value":240189.982,"total_display":"240,189.98","total_whole":"240,190","shares_owned_after":4926033.0,"shares_owned_after_display":"4,926,033","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-12","filed_date":"2014-08-12","scope":"insider"},{"id":7066888,"accession":"0001181431-14-028995","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-14-028995","line_url":"/filing/0001181431-14-028995#line-1","is_derivative":false,"issuer_cik":"0001061027","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001061027","owner_cik":null,"owner_name":"Growth Equity Opportunities Fund, LLC; New Enterprise Associates 12, Limited Partnership; NEA 12 GP, LLC; NEA Partners 12, Limited Partnership","owner_display_name":"Growth Equity Opportunities Fund, LLC","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":4,"other_reporting_owners":3,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":675000.0,"shares_display":"675,000","price_per_share":6.6201,"price_display":"6.62","price_state":"stated","total_value":4468567.5,"total_display":"4,468,567.50","total_whole":"4,468,568","shares_owned_after":4961573.0,"shares_owned_after_display":"4,961,573","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-08-08","filed_date":"2014-08-12","scope":"insider"},{"id":8939765,"accession":"0001181431-11-017713","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-11-017713","line_url":"/filing/0001181431-11-017713#line-1","is_derivative":false,"issuer_cik":"0001005544","issuer_name":"ARYx Therapeutics, Inc.","issuer_ticker":"ARYX","issuer_name_source":null,"issuer_url":"/issuer/0001005544","owner_cik":null,"owner_name":"PERRY MARK W; NEA 12 GP, LLC; Growth Equity Opportunities Fund, LLC; NEA Partners 12, Limited Partnership; SANDELL SCOTT D; BARRETT M JAMES; NEWHALL CHARLES W III; New Enterprise Associates 12, Limited Partnership; KRAMLICH C RICHARD; BARRIS PETER J","owner_display_name":"PERRY MARK W","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4469274.0,"shares_display":"4,469,274","price_per_share":0.073,"price_display":"0.07","price_state":"stated","total_value":326257.002,"total_display":"326,257.00","total_whole":"326,257","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-03-10","filed_date":"2011-03-14","scope":"insider"},{"id":7666938,"accession":"0001181431-10-035797","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-10-035797","line_url":"/filing/0001181431-10-035797#line-2","is_derivative":false,"issuer_cik":"0001005544","issuer_name":"SUNESIS PHARMACEUTICALS INC","issuer_ticker":"SNSS","issuer_name_source":null,"issuer_url":"/issuer/0001005544","owner_cik":null,"owner_name":"New Enterprise Associates 12, Limited Partnership; NEA Partners 12, Limited Partnership; KRAMLICH C RICHARD; NEWHALL CHARLES W III; BARRIS PETER J; PERRY MARK W; BARRETT M JAMES; SANDELL SCOTT D; Growth Equity Opportunities Fund, LLC; NEA 12 GP, LLC","owner_display_name":"New Enterprise Associates 12, Limited Partnership","owner_url":null,"role":"Ten percent owner","role_mark":null,"role_mark_label":"Not attributed","role_mark_generic":"Not stated","n_reporting_owners":10,"other_reporting_owners":9,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":23824451.0,"shares_display":"23,824,451","price_per_share":0.275,"price_display":"0.28","price_state":"stated","total_value":6551724.025,"total_display":"6,551,724.02","total_whole":"6,551,724","shares_owned_after":23824451.0,"shares_owned_after_display":"23,824,451","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-06-30","filed_date":"2010-07-02","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":0,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":0},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001061027","name":"SUNESIS PHARMACEUTICALS INC","url":"/issuer/0001061027","role":"Ten percent owner","n_filings":3,"first_seen":"2010-07-02","last_seen":"2014-08-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001410064","name":"ARYx Therapeutics, Inc.","url":"/issuer/0001410064","role":"Ten percent owner","n_filings":1,"first_seen":"2011-03-14","last_seen":"2011-03-14"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001448784","retrieved_at":"2026-08-23T12:03:19+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}